Breathermae Secures $350K Pre-Seed Funding, Ushering in a New Era of Bio-Energetic HealthTech Innovation

BREATHERMAE is thrilled to announce that the company has successfully raised $350,000 in funding, marking a major milestone in its mission to revolutionize the healthcare landscape. As a pioneering Bio-Energetic HealthTech firm, BREATHERMAE is leveraging cutting-edge technology, including advanced AGI and patentable predictive analysis software paired with novel API tools, to expand the analysis of code within the healthcare industry. This fresh infusion of capital will further fuel the development of our comprehensive, multi-dimensional approach, which uniquely integrates bio-energetic diagnostic tools with restorative health solutions. By acknowledging that patient care goes beyond mere physical treatment, BREATHERMAE is addressing the often-overlooked mental, emotional, and energetic aspects of healing, thereby ensuring that the complete human cycle of existence is cared for. With this new funding, we plan to accelerate the integration of our device-based diagnostics with established allopathic medicine practices, bridging traditional healthcare with innovative restorative solutions. An integral part of our vision includes the rollout of the Art of Wellness Mobile app alongside a groundbreaking lineup of products, all designed to energetically restore balance and maintain homeostasis. Our goal is to improve patient outcomes, reduce healthcare costs, and ultimately provide a globally inclusive approach to HealthTech access. This funding milestone not only substantiates the market’s confidence in the BREATHERMAE model but also reinforces our commitment to delivering a quantum leap forward in restorative healthcare innovation, ensuring that every individual benefits from a truly holistic approach to wellness.